FRONTOTEMPORAL DEMENTIA

Clinical trials for FRONTOTEMPORAL DEMENTIA explained in plain language.

Never miss a new study

Get alerted when new FRONTOTEMPORAL DEMENTIA trials appear

Sign up with your email to follow new studies for FRONTOTEMPORAL DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 11 Completed 11 Terminated 1

Promising dementia drug trial halted early – what happened?

Disease control Terminated

This study tested a drug called AL001 in people who have a gene mutation that puts them at risk for or already causes frontotemporal dementia (FTD). The goal was to see if AL001 could slow down the disease. The trial was stopped early, so we don't have final results on whether it…

Matched conditions: FRONTOTEMPORAL DEMENTIA

Phase: PHASE3 • Sponsor: Alector Inc. • Aim: Disease control

Last updated Jun 15, 2026 19:04 UTC

FRONTOTEMPORAL DEMENTIA

Get alerted when new FRONTOTEMPORAL DEMENTIA trials appear

Promising dementia drug trial halted early – what happened?